Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteinase Inhibitory Proteins, Secretory | 23 | 2024 | 49 | 2.860 |
Why?
|
Serine Endopeptidases | 19 | 2023 | 1027 | 1.810 |
Why?
|
Transcription Factor RelA | 4 | 2022 | 253 | 1.200 |
Why?
|
Receptor, PAR-2 | 3 | 2020 | 33 | 0.950 |
Why?
|
Adrenomedullin | 2 | 2023 | 85 | 0.920 |
Why?
|
Supratentorial Neoplasms | 2 | 2022 | 159 | 0.830 |
Why?
|
Glioblastoma | 10 | 2018 | 3525 | 0.790 |
Why?
|
Ependymoma | 2 | 2022 | 328 | 0.720 |
Why?
|
Mouth Neoplasms | 3 | 2021 | 597 | 0.680 |
Why?
|
Membrane Glycoproteins | 10 | 2023 | 3713 | 0.650 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2020 | 182 | 0.640 |
Why?
|
Brain Neoplasms | 11 | 2022 | 9213 | 0.580 |
Why?
|
Gene Fusion | 1 | 2020 | 357 | 0.570 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 2 | 2007 | 69 | 0.570 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 314 | 0.570 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1064 | 0.550 |
Why?
|
NF-kappa B | 5 | 2024 | 2492 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2023 | 567 | 0.530 |
Why?
|
Cytoplasm | 1 | 2019 | 1505 | 0.490 |
Why?
|
Colitis | 3 | 2023 | 1242 | 0.480 |
Why?
|
DNA Repair | 2 | 2021 | 2054 | 0.440 |
Why?
|
Hepatocyte Growth Factor | 7 | 2023 | 269 | 0.440 |
Why?
|
Neoplasm Invasiveness | 8 | 2021 | 3629 | 0.430 |
Why?
|
Cyclohexanones | 2 | 2016 | 30 | 0.420 |
Why?
|
Hematopoietic Stem Cells | 5 | 2022 | 3408 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2022 | 4064 | 0.400 |
Why?
|
Gene Expression | 4 | 2024 | 7603 | 0.360 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2023 | 356 | 0.330 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 83 | 0.330 |
Why?
|
Epithelium | 3 | 2023 | 1607 | 0.330 |
Why?
|
Wound Healing | 3 | 2018 | 2815 | 0.320 |
Why?
|
Leukemia, Myeloid | 3 | 2022 | 693 | 0.310 |
Why?
|
Macrophage Migration-Inhibitory Factors | 2 | 2005 | 109 | 0.300 |
Why?
|
Mice | 38 | 2023 | 82072 | 0.290 |
Why?
|
Cell Line, Tumor | 17 | 2021 | 17173 | 0.290 |
Why?
|
Mutation | 11 | 2024 | 30266 | 0.280 |
Why?
|
Benzamides | 2 | 2016 | 1387 | 0.280 |
Why?
|
Keratinocytes | 3 | 2024 | 876 | 0.280 |
Why?
|
Dacarbazine | 1 | 2009 | 559 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2017 | 1756 | 0.270 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 957 | 0.270 |
Why?
|
Calcium | 1 | 2019 | 5792 | 0.270 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2022 | 686 | 0.260 |
Why?
|
Nutritional Status | 1 | 2014 | 1627 | 0.250 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2517 | 0.250 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 618 | 0.250 |
Why?
|
Animals | 45 | 2024 | 169335 | 0.250 |
Why?
|
Cell Proliferation | 11 | 2021 | 10486 | 0.250 |
Why?
|
Epithelial Cells | 6 | 2020 | 3702 | 0.250 |
Why?
|
Kallikreins | 3 | 2020 | 219 | 0.240 |
Why?
|
Repressor Proteins | 3 | 2021 | 2986 | 0.240 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2019 | 1616 | 0.230 |
Why?
|
DNA Methylation | 1 | 2018 | 4432 | 0.230 |
Why?
|
Basement Membrane | 1 | 2024 | 348 | 0.220 |
Why?
|
Neurofibrosarcoma | 1 | 2023 | 28 | 0.220 |
Why?
|
Mice, Nude | 6 | 2018 | 3631 | 0.210 |
Why?
|
Neoplastic Stem Cells | 2 | 2022 | 1356 | 0.210 |
Why?
|
Pancreatic Neoplasms | 5 | 2017 | 5443 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2023 | 2848 | 0.200 |
Why?
|
TATA Box | 1 | 2021 | 127 | 0.190 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2023 | 170 | 0.190 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2022 | 430 | 0.190 |
Why?
|
Phlebovirus | 1 | 2021 | 2 | 0.190 |
Why?
|
Epidermis | 1 | 2024 | 539 | 0.190 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2022 | 75 | 0.190 |
Why?
|
Cytosine Deaminase | 1 | 2021 | 65 | 0.190 |
Why?
|
Thymidine | 1 | 2021 | 297 | 0.190 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2021 | 18 | 0.190 |
Why?
|
Mice, Inbred BALB C | 10 | 2020 | 6232 | 0.190 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2024 | 633 | 0.190 |
Why?
|
Rhabdomyoma | 1 | 2021 | 56 | 0.190 |
Why?
|
Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3626 | 0.180 |
Why?
|
Microsatellite Instability | 1 | 2024 | 726 | 0.180 |
Why?
|
Cell Movement | 7 | 2021 | 5216 | 0.180 |
Why?
|
Protein Precursors | 2 | 2018 | 1135 | 0.180 |
Why?
|
Intestinal Mucosa | 5 | 2019 | 3044 | 0.170 |
Why?
|
Tracheoesophageal Fistula | 1 | 2021 | 131 | 0.170 |
Why?
|
Tongue Neoplasms | 1 | 2022 | 186 | 0.170 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 308 | 0.170 |
Why?
|
Frontal Lobe | 2 | 2020 | 1426 | 0.170 |
Why?
|
Myelodysplastic Syndromes | 2 | 2022 | 1399 | 0.160 |
Why?
|
Palliative Care | 1 | 2014 | 3644 | 0.160 |
Why?
|
Humans | 63 | 2024 | 768970 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 465 | 0.160 |
Why?
|
Glioma, Subependymal | 1 | 2017 | 3 | 0.150 |
Why?
|
Neurilemmoma | 1 | 2023 | 524 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2812 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2211 | 0.150 |
Why?
|
Up-Regulation | 3 | 2024 | 4148 | 0.150 |
Why?
|
Signal Transduction | 7 | 2021 | 23653 | 0.150 |
Why?
|
HEK293 Cells | 3 | 2022 | 4290 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2021 | 374 | 0.140 |
Why?
|
Neovascularization, Pathologic | 3 | 2020 | 2634 | 0.140 |
Why?
|
Gene Silencing | 3 | 2019 | 1505 | 0.140 |
Why?
|
Keratins | 2 | 2015 | 502 | 0.140 |
Why?
|
Trypsin Inhibitor, Kunitz Soybean | 2 | 2023 | 11 | 0.130 |
Why?
|
Hydrocephalus | 1 | 2022 | 770 | 0.130 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2018 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2020 | 840 | 0.120 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2431 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2063 | 0.120 |
Why?
|
Desmosomes | 1 | 2015 | 73 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1231 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8664 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1520 | 0.120 |
Why?
|
Hematopoiesis | 2 | 2022 | 2059 | 0.120 |
Why?
|
Microvessels | 1 | 2019 | 586 | 0.120 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2016 | 219 | 0.120 |
Why?
|
Male | 31 | 2024 | 365203 | 0.120 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 658 | 0.120 |
Why?
|
Astrocytoma | 1 | 2019 | 781 | 0.120 |
Why?
|
Disease Progression | 4 | 2021 | 13674 | 0.120 |
Why?
|
Ganglioneuroma | 1 | 2014 | 53 | 0.120 |
Why?
|
Sarcoma | 1 | 2005 | 1806 | 0.110 |
Why?
|
Adipocytes, White | 1 | 2014 | 92 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4592 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2017 | 453 | 0.110 |
Why?
|
Adipocytes, Brown | 1 | 2014 | 160 | 0.110 |
Why?
|
Ghrelin | 1 | 2015 | 251 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1226 | 0.110 |
Why?
|
Prognosis | 6 | 2024 | 30046 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9442 | 0.110 |
Why?
|
Tuberous Sclerosis | 1 | 2021 | 1042 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1258 | 0.110 |
Why?
|
Gastrins | 1 | 2012 | 75 | 0.100 |
Why?
|
Serine Proteases | 1 | 2012 | 44 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2011 | 3621 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 22379 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1183 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2023 | 1902 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2603 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 788 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 693 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3200 | 0.100 |
Why?
|
Ganglioglioma | 1 | 2011 | 36 | 0.100 |
Why?
|
Mediastinal Neoplasms | 1 | 2014 | 403 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1672 | 0.090 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2011 | 16 | 0.090 |
Why?
|
Trophoblasts | 1 | 2012 | 223 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1752 | 0.090 |
Why?
|
Inflammation | 3 | 2018 | 10868 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2019 | 7885 | 0.090 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6982 | 0.090 |
Why?
|
Immunoblotting | 2 | 2010 | 1647 | 0.090 |
Why?
|
Astrocytes | 1 | 2018 | 1349 | 0.090 |
Why?
|
Phosphorylation | 3 | 2018 | 8317 | 0.090 |
Why?
|
Mice, Knockout | 9 | 2023 | 14484 | 0.090 |
Why?
|
Laminin | 2 | 2012 | 406 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11932 | 0.090 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4300 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9549 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2395 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2960 | 0.080 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1395 | 0.080 |
Why?
|
Oligodendroglioma | 1 | 2011 | 278 | 0.080 |
Why?
|
Laparoscopy | 1 | 2021 | 2055 | 0.080 |
Why?
|
Hyperplasia | 1 | 2012 | 1154 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2110 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18354 | 0.080 |
Why?
|
Blood Vessels | 1 | 2014 | 1110 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11116 | 0.080 |
Why?
|
Mice, Transgenic | 5 | 2021 | 9565 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4363 | 0.080 |
Why?
|
Ichthyosis | 1 | 2008 | 59 | 0.080 |
Why?
|
Tissue Kallikreins | 1 | 2008 | 14 | 0.080 |
Why?
|
Apoptosis | 5 | 2021 | 9527 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2542 | 0.070 |
Why?
|
Adult | 14 | 2024 | 223851 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5707 | 0.070 |
Why?
|
Median Nerve | 1 | 2008 | 133 | 0.070 |
Why?
|
Oligodendroglia | 1 | 2011 | 540 | 0.070 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.070 |
Why?
|
Female | 23 | 2024 | 397515 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3532 | 0.070 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2008 | 133 | 0.070 |
Why?
|
Ovalbumin | 1 | 2008 | 677 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 5801 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5196 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1658 | 0.070 |
Why?
|
Sarcoma, Synovial | 1 | 2008 | 156 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13698 | 0.070 |
Why?
|
Arthritis, Experimental | 1 | 2008 | 293 | 0.070 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2007 | 174 | 0.070 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2007 | 189 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2011 | 866 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13594 | 0.060 |
Why?
|
Cell Hypoxia | 1 | 2008 | 662 | 0.060 |
Why?
|
Neoplasms | 5 | 2018 | 22389 | 0.060 |
Why?
|
Mesoderm | 1 | 2009 | 679 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2056 | 0.060 |
Why?
|
Cell Membrane | 2 | 2013 | 3659 | 0.060 |
Why?
|
Lymphatic Metastasis | 3 | 2021 | 2916 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59739 | 0.060 |
Why?
|
Chorioallantoic Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2024 | 19023 | 0.060 |
Why?
|
Placentation | 1 | 2005 | 78 | 0.060 |
Why?
|
Ubiquitination | 2 | 2021 | 1010 | 0.060 |
Why?
|
Hair | 1 | 2008 | 509 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 850 | 0.060 |
Why?
|
Mice, Inbred ICR | 1 | 2005 | 363 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2734 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 809 | 0.060 |
Why?
|
Mice, SCID | 2 | 2023 | 2631 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2015 | 1907 | 0.060 |
Why?
|
Middle Aged | 12 | 2024 | 223737 | 0.050 |
Why?
|
Interferon Type I | 1 | 2007 | 569 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2005 | 794 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2011 | 1728 | 0.050 |
Why?
|
Transcription Factors | 2 | 2020 | 12174 | 0.050 |
Why?
|
Dextran Sulfate | 2 | 2015 | 258 | 0.050 |
Why?
|
Cell Cycle | 2 | 2021 | 2937 | 0.050 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2022 | 958 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1911 | 0.050 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 930 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3057 | 0.050 |
Why?
|
Fibrinolysin | 1 | 2022 | 130 | 0.050 |
Why?
|
Plasminogen | 1 | 2022 | 144 | 0.050 |
Why?
|
Carcinogens | 2 | 2015 | 453 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8745 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2022 | 125 | 0.050 |
Why?
|
Aged | 10 | 2024 | 171786 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8513 | 0.050 |
Why?
|
Morphogenesis | 1 | 2005 | 747 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 3 | 2009 | 4528 | 0.050 |
Why?
|
Ticks | 1 | 2021 | 71 | 0.050 |
Why?
|
Tick-Borne Diseases | 1 | 2021 | 37 | 0.050 |
Why?
|
Homozygote | 2 | 2022 | 1780 | 0.050 |
Why?
|
Twins, Dizygotic | 1 | 2021 | 236 | 0.040 |
Why?
|
Drug Combinations | 1 | 2007 | 2089 | 0.040 |
Why?
|
Colony-Forming Units Assay | 1 | 2020 | 351 | 0.040 |
Why?
|
Permeability | 2 | 2013 | 726 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2010 | 6131 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2021 | 297 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1608 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 328 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 422 | 0.040 |
Why?
|
Bone Marrow | 2 | 2021 | 2936 | 0.040 |
Why?
|
Gene Deletion | 3 | 2013 | 2674 | 0.040 |
Why?
|
Spleen | 1 | 2005 | 2294 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 50 | 0.040 |
Why?
|
Collagen | 1 | 2007 | 2646 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3810 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18068 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 36854 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2005 | 1803 | 0.040 |
Why?
|
Claudins | 1 | 2019 | 117 | 0.040 |
Why?
|
HeLa Cells | 2 | 2018 | 3076 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 719 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6673 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2022 | 1498 | 0.040 |
Why?
|
Whole-Body Irradiation | 1 | 2018 | 435 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1013 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2021 | 2460 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3139 | 0.040 |
Why?
|
Fetal Development | 1 | 2022 | 777 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2010 | 12806 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1667 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 271 | 0.030 |
Why?
|
Japan | 1 | 2021 | 1418 | 0.030 |
Why?
|
Models, Biological | 3 | 2009 | 9499 | 0.030 |
Why?
|
Culture Media, Serum-Free | 1 | 2016 | 148 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 725 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1836 | 0.030 |
Why?
|
Neurogenesis | 1 | 2022 | 865 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2021 | 3473 | 0.030 |
Why?
|
Azoxymethane | 1 | 2015 | 32 | 0.030 |
Why?
|
Esophagus | 1 | 2021 | 1043 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1866 | 0.030 |
Why?
|
Trachea | 1 | 2021 | 1095 | 0.030 |
Why?
|
Regeneration | 1 | 2004 | 1524 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2022 | 895 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10115 | 0.030 |
Why?
|
Protein Stability | 1 | 2017 | 580 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1273 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 521 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2022 | 1281 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 703 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2016 | 278 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2024 | 2059 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 967 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 3612 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1540 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1181 | 0.030 |
Why?
|
Parietal Cells, Gastric | 1 | 2012 | 39 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2149 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2414 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2009 | 3588 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 564 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4413 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 745 | 0.030 |
Why?
|
Cesarean Section | 1 | 2021 | 1426 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2014 | 963 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3726 | 0.020 |
Why?
|
Pregnancy | 3 | 2021 | 30265 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 326 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4651 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27453 | 0.020 |
Why?
|
Azetidines | 1 | 2012 | 152 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26428 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2748 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2472 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5763 | 0.020 |
Why?
|
Time Factors | 3 | 2007 | 40261 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2709 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2011 | 385 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4207 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3539 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 755 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2012 | 602 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2013 | 1839 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 640 | 0.020 |
Why?
|
Animal Structures | 1 | 2008 | 26 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 663 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3952 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6805 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6512 | 0.020 |
Why?
|
Skin | 2 | 2015 | 4506 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2009 | 244 | 0.020 |
Why?
|
Skin Abnormalities | 1 | 2008 | 60 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1194 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15604 | 0.020 |
Why?
|
Serum | 1 | 2009 | 207 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 283 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2008 | 262 | 0.020 |
Why?
|
Injections, Intra-Articular | 1 | 2008 | 288 | 0.020 |
Why?
|
Chimera | 1 | 2008 | 454 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 1647 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4428 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9384 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5342 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 1970 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9618 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4478 | 0.020 |
Why?
|
Serpins | 1 | 2008 | 246 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10276 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1371 | 0.020 |
Why?
|
Embryo Loss | 1 | 2005 | 55 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 930 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2006 | 326 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2004 | 125 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2011 | 1794 | 0.010 |
Why?
|
Cadherins | 1 | 2009 | 906 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 600 | 0.010 |
Why?
|
Antigens | 1 | 2008 | 1444 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11684 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1956 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5716 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1676 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10099 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5033 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4774 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13021 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3836 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2553 | 0.010 |
Why?
|
Gene Targeting | 1 | 2005 | 841 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1251 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1904 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 2004 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2543 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3433 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3775 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1966 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2005 | 1526 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4353 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2827 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1891 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81903 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4168 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9344 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36556 | 0.010 |
Why?
|
Antigens, CD | 1 | 2009 | 4032 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60131 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16731 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 3283 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11262 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1629 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5804 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42683 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4926 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4625 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4413 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6401 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74976 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12430 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12873 | 0.010 |
Why?
|
Child | 1 | 2019 | 80960 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89244 | 0.010 |
Why?
|